MedAdvisor Limited Launches Strategic Review for Growth

MedAdvisor Limited (AU:MDR) has released an update.

MedAdvisor Limited, a global pharmacy-driven patient engagement firm, has initiated a strategic review to enhance shareholder value, as it believes its current market valuation does not reflect the true worth of its Australian and US operations. The company, which recently achieved profitability, aims to explore various initiatives to bridge this valuation gap while continuing its growth plans. Financial experts Adelaide Equity Partners Limited and legal advisors HWL Ebsworth have been engaged to assist with the review.

For further insights into AU:MDR stock, check out TipRanks’ Stock Analysis page.